OpenEvidence Revolutionizes Medical Decision-Making with Hands-Free Voice AI Feature
OpenEvidence, a leader in AI-driven medical solutions, has introduced an innovative voice AI feature to its widely-used medical search engine. This cutting-edge development allows healthcare professionals to ask questions hands-free, receiving evidence-based answers efficiently.
A New Era of Multimodal Medical AI
Dubbed “Voice Mode,” this feature represents a significant advancement as the first multimodal medical AI offering for clinical decision support, according to OpenEvidence. Available on both web and mobile apps, the feature is accessible to all users at no cost.
Medical professionals can leverage the voice mode while transitioning between rooms, conducting rounds, or multitasking, such as drawing charts or managing phone calls. This adaptability enhances the user experience by integrating seamlessly into the dynamic hospital environment.
Positive Reception and Practical Applications
The voice mode feature has undergone extensive beta testing, receiving overwhelmingly positive feedback. Daniel Nadler, founder and CEO of OpenEvidence, shared insights with Fierce Healthcare, highlighting the feature’s practical applications.
“Doctors have mentioned using voice mode to query information while commuting or even in the shower, enabling them to address complex cases with greater ease,” Nadler stated.
To utilize this feature, doctors simply tap an orange waveform icon, pose their question, and receive concise spoken answers. These responses are grounded in reputable sources like the New England Journal of Medicine, JAMA, Cochrane, and NCCN, ensuring high-quality information delivery.
Enhancing Medical AI with Intelligent Interfaces
“Building medical AI involves focusing on both intelligence and interface. We’ve dedicated years to refining the intelligence, and now, with voice mode, we’re evolving the interface to fit the realities of medical practice,” Nadler explained.
OpenEvidence’s AI-powered medical search engine and generative AI chatbot cater exclusively to physicians, streamlining access to evidence-based medical information. With over 860,000 medically licensed and verified U.S. clinicians utilizing the platform, OpenEvidence serves a significant portion of the medical community.
Financial Growth and Expansion
In January, OpenEvidence closed a $250 million Series D funding round, doubling its valuation to $12 billion. This follows a $200 million Series C round in October and a $210 million Series B round in July, culminating in approximately $700 million raised last year.
The company now handles over 1 million clinical questions daily, serving more than 10,000 hospitals and medical centers nationwide. OpenEvidence’s expansion into various clinical workflows positions it alongside competitors like Wolters Kluwer’s UpToDate and Elsevier.
Practical Features for Real-World Use
The voice mode function is designed for use beyond the confines of a workstation, offering shorter, listener-friendly responses. The accompanying written transcripts and references maintain the standard of review akin to written responses. Additionally, users can mute the microphone in noisy environments or opt for a text-based input mode.
Ania Bilski, MD, vice president of clinical AI at OpenEvidence and an emergency physician, emphasized the feature’s practicality: “Voice mode provides the answers I need during those in-between moments in the ER.”
Integrating AI in Healthcare Systems
OpenEvidence is expanding its presence in hospitals and health systems. Recent collaborations with Mount Sinai, Sutter Health, and Cedars-Sinai aim to integrate its AI-based platform into electronic health record systems. These partnerships enable clinicians to access medical literature relevant to individual patient profiles.
“Advertising has historically supported access to medical research, and our ad-supported model maintains clinical integrity and supports high-quality care,” Shaun Miller, MD, chief health informatics officer at Cedars-Sinai, noted.
Nadler revealed plans for a corporate model, similar to Anthropic’s, offering customizable options for large systems seeking enterprise-wide solutions beyond the core OpenEvidence product.
Enterprise-Wide Rollouts and Future Vision
Cedars-Sinai’s enterprise-wide deployment aligns with its broader AI strategy, integrating AI directly into clinical workflows. Health systems are responding to strong demand from physicians for integrated AI solutions, reflecting a commitment to advanced precision healthcare.
Mount Sinai’s Nicholas Gavin, MD, emphasized the transformative potential of such tools, stating, “Our goal is to integrate real-time patient data with the latest evidence to provide precise insights and guidance to our clinical team.”
This strategic integration of AI into healthcare systems aims to enhance clinical decision-making, ensuring clinicians deliver high-quality care efficiently and effectively.
For more details, visit the source here.
“`
